S Samanta, J Banerjee, A Das, S Das, R Ahmed… - Current …, 2024 - Springer
A growing number of re-infections with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in previously immunized individuals has sparked discussions about the …
GAML Costanzo, CM Deiana, G Sanna, A Perra… - Journal of Clinical …, 2024 - Springer
Purpose The purpose of this study is to investigate the kinetics of response against SARS- CoV-2 elicited by vaccination and/or breakthrough infection (occurred after 3 doses of …
C Vanetti, M Stracuzzi, E Crivellaro, F Ciciliano… - Frontiers in …, 2024 - frontiersin.org
Background Data on the efficacy of three SARS-CoV-2 mRNA BNT162b2 vaccine doses and the role of previous SARS-CoV-2-infection in enhancing vaccine immunogenicity in HIV …
VC Pitiriga, M Papamentzelopoulou… - Vaccines, 2024 - mdpi.com
Introduction: Exploring T cell response duration is pivotal for understanding immune protection evolution in natural SARS-CoV-2 infections. The objective of the present study …
CL Smith, E Didion, H Aung… - The Journal of …, 2024 - academic.oup.com
Background Vaccines and vaccine boosting have blunted excess morbidity and mortality from SARS-CoV-2 infection suffered by older nursing home residents (NHR). However, the …
G Almanzar, K Koosha, T Vogt, A Stein… - Journal of Medical …, 2024 - Wiley Online Library
This longitudinal prospective controlled multicenter study aimed to monitor immunity generated by three exposures caused by breakthrough infections (BTI) after COVID‐19 …
M Capone, A Vanni, L Salvati, G Lamacchia… - Immunology …, 2024 - Elsevier
Objective Novel mRNA-based vaccines have been proven to be powerful tools in combating the global pandemic caused by SARS-CoV-2 protecting individuals, especially the …